SEBI Approves Four IPOs in 2026: Integris Medtech, Alpine Texworld & More

SEBI Clears Four Major IPOs in 2026: Full Overview and Key Details

The Securities and Exchange Board of India (SEBI) has recently approved the IPO proposals of four companies, marking a significant boost to the Indian primary market pipeline. The approvals signal renewed investor optimism and diversification across sectors such as medical technology, textiles, lab-grown diamonds and industrial packaging. The approved IPOs include Integris Medtech, Alpine Texworld, Anjali Labtech and Appl Containers. All four companies are expected to list their shares on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) once the subscription and allotment processes are completed.

Among the four issuers, Integris Medtech tops the list with one of the largest planned fundraising exercises this year. The company, backed by private equity firm Everstone Capital, has received the nod for an IPO that includes a fresh issue of equity shares with a face value of Re 1 each, aiming to raise up to ₹925 crore. In addition to the fresh issue, the offer includes an Offer for Sale (OFS) of 2,16,74,531 equity shares by existing promoters and shareholders. The OFS portion will involve the sale of shares by Evercure Holdings, which may offload up to 1,51,74,251 shares, while founders Gurmit Singh Chugh and Punita Sharma may sell 32,50,140 shares each as part of the process. The company has also indicated the possibility of a pre-IPO placement of up to ₹185 crore before moving ahead with the final prospectus filing.

The net proceeds from Integris Medtech’s fresh issue are proposed to be primarily deployed for debt reduction, with approximately ₹696.39 crore earmarked for prepayment or repayment of loans taken by its subsidiaries, and the remainder intended for general corporate purposes. The company is regarded as one of India’s fastest-growing medtech platforms, with diversified offerings in cardiovascular and laboratory solutions, making this a highly anticipated IPO among investors.

Alpine Texworld, another company cleared by SEBI, is planning a fresh issue of 1.50 crore equity shares structured as a book-built offer. The textile-focused company is expected to utilise funds for business expansion, including new manufacturing facilities and capacity enhancement. The book-running lead manager for this issue is D & A Financial Services, while Kfin Technologies has been appointed as the registrar for the IPO.

Based in Surat, Anjali Labtech has also secured approval for its IPO. The company operates in the burgeoning lab-grown diamond and advanced materials segment, manufacturing diamonds, diamond jewellery, semiconductor substrates, and microwave plasma chemical vapour deposition (MPCVD) systems. The IPO is expected to support the company’s growth plans, helping it strengthen its position in global markets and expand its product offerings across B2B and B2C channels.

The fourth IPO clearance was granted to Appl Containers, which proposes a book-built issue of 38,00,000 equity shares, consisting of a fresh issue of 13,00,000 shares and an OFS of 26,00,000 shares. This company specialises in industrial containers and packaging solutions, catering to sectors that require safe and durable transport of liquids and chemicals. Cumulative Capital is managing this issue as the book-running lead manager, while Bigshare Services serves as the issuer registrar.

SEBI’s approval for these four IPOs reflects a broadening of opportunities in the Indian capital markets. Integris Medtech’s large-scale issue is among the most prominent, while Alpine Texworld, Anjali Labtech and Appl Containers aim to raise funds for capacity expansion, debt management and market penetration. These IPOs will likely attract attention from both institutional and retail investors, offering opportunities across technology, manufacturing and innovative product domains.

Investors keen on participating in these offerings should watch for forthcoming filing details, price bands, subscription timelines and allotment dates as the companies move closer to launching their public issues.